Last updated: 07-20-2021

I Am Translational Science


NCATS’ I Am Translational Science video series shares the stories of people working in translational science. Translational science emphasizes collaboration, innovation, systems approaches and knowledge integration across disciplines to understand and address the many scientific and operational bottlenecks that exist along the road from laboratory discovery to public health intervention.

The stories shared here by researchers and others are about what they do, what inspires their work and why they find translational science exciting. The initial stories feature those involved in COVID-19 efforts. Learn more about NCATS’ translational approach to addressing the pandemic.

Follow the #IamTranslationalScience hashtag on Twitter or check back each month for new stories about innovative research that is advancing translational science.

Christopher P. Austin, M.D., Flagship Pioneering

Christopher P. Austin, M.D., CEO-Partner at Flagship Pioneering and former NCATS director, says that a revolution in basic research has increased our understanding of diseases but there has not been a commensurate increase in our ability to diagnose, treat and cure them. He explains how NCATS and translational science focus on developing solutions to problems along the path of turning scientific discoveries into treatments to benefit patients. Learn more about the impact and potential future of translational science in Dr. Austin’s article, “Opportunities and Challenges in Translational Science.”

Posted July 19, 2021

A version of this video with audio description is available.

Anne R. Pariser, M.D., NCATS, ORDR

Anne R. Pariser, M.D., NCATS, ORDR, director of the NCATS Office of Rare Diseases Research, discusses how focusing on research barriers that are common to many rare diseases can help speed the development of treatments for multiple diseases. She discusses the NCATS-led Platform Vector Gene Therapy program (PaVe-GT), which aims to increase the efficiency of gene therapy trial startup by using a standardized process.

Posted March 3, 2021

A version of this video with audio description is available.

Mustafa Sahin, M.D., Ph.D., Boston Children’s Hospital, Harvard Medical School

Mustafa Sahin, M.D., Ph.D., child neurologist at Boston Children’s Hospital and Harvard Medical School, shares how advances in translation have helped his team provide new treatments to young patients with rare neurodevelopmental disorders. Dr. Sahin, who is part of the NCATS-led Rare Diseases Clinical Research Network, discusses his hopes for better tools, such as biomarkers, to identify improvements in brain function and behavioral outcomes of patients.

Posted February 22, 2021

A version of this video with audio description is available.

Lucie A. Low, Ph.D., NCATS

As the scientific program manager of the trans-NIH Tissue Chip for Drug Screening program, NCATS’ Lucie A. Low, Ph.D., works with diverse teams across the country to help develop and research tissue chips. She highlights the importance of seeking solutions through teamwork and collaboration in order to accelerate the translation of observations into interventions to improve health.

Posted February 8, 2021

A version of this video with audio description is available.

Hongfang Liu, Ph.D., Mayo Clinic

Hongfang Liu, Ph.D., program director for informatics at Mayo Clinic, is experienced in using clinical data for translational science research and improving health care delivery. Dr. Liu explains how collaborating with experts in other disciplines to build the National COVID Cohort Collaborative (N3C) Data Enclave will advance the science behind COVID-19 to deliver health care interventions and treatments.

Posted November 24, 2020

A version of this video with audio description is available.

Brittany M. Haynes, Ph.D., NCATS

As a cancer biology researcher, Brittany M. Haynes, Ph.D., learned firsthand the challenges that keep laboratory discoveries from becoming medical treatments. Now, as a scientific program specialist in the Education Branch at NCATS, Dr. Haynes helps young scientists acquire the translational science skills needed to pursue a broad range of scientific careers. She explains how the team sport of translational science shortens a treatment’s journey from benchtop to bedside.

Posted October 20, 2020

A version of this video with audio description is available.

Carleen Klumpp-Thomas, M.S., NCATS

NCATS’ Carleen Klumpp-Thomas has always been fascinated by viruses. Now that interest is helping to drive her work collaborating with others at NIH on a study to determine the spread of COVID-19 in the United States, especially among people who might not have known they were infected.

Posted August 13, 2020

A version of this video with audio description is available.

Kirill Gorshkov, Ph.D., NCATS

Kirill Gorshkov is part of the team at NCATS conducting research to respond to the COVID-19 pandemic. Dr. Gorshkov talks about his role on multiple projects and how earlier translational science efforts laid the groundwork for NCATS to quickly mobilize for COVID-19 research.

Posted August 6, 2020

A version of this video with audio description is available.”

Chang Hee Kim, Ph.D., GoDiagnostics (GoDx)

Chang Hee Kim, CEO of GoDx, talks about what it’s like to conduct research during a pandemic and how a translational science approach is essential to fighting COVID-19. With funding from NCATS’ Small Business Innovation Research program, GoDx is adapting its technology platform into a quick, simple and inexpensive approach that could detect the novel coronavirus from nasopharyngeal or saliva samples in less than 30 minutes.

Posted July 29, 2020

A version of this video with audio description is available.